News

Zacks Investment Research on MSN19h
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?
Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...
Sagapixel: GLP-1 Surpasses Ozempic In Search Volume, Signaling A New Era In Patient Awareness And Provider Strategy
As of Q1 2025, searches for“GLP-1” now average over 3 million monthly queries, outpacing Ozempic, which has declined from its peak of 6 million in early 2024. This shift reflects a more informed, ...